Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.

Autor: Maurits S Buiten, Mihály K de Bie, Joris I Rotmans, Friedo W Dekker, Marjolijn van Buren, Ton J Rabelink, Christa M Cobbaert, Martin J Schalij, Arnoud van der Laarse, J Wouter Jukema

Publikováno v: PLoS ONE, Vol 10, Iss 8, p e0134245 (2015)

Serum troponin assays, widely used to detect acute cardiac ischemia, might be useful biomarkers to detect chronic cardiovascular disease (CVD). Cardiac-specific troponin-I (cTnI) and troponin-T (cTnT) generally detect myocardial necrosis equally well

Externí odkaz: https://doaj.org/article/90e270afa0bf4b268b64551bfc8a73b8

The impact of transvenous cardioverter-defibrillator implantation on quality of life, depression and optimism in dialysis patients: report on the secondary outcome of QOL in the randomized controlled ICD2 trial

Autor: Mihály K. de Bie, Martin J. Schalij, Rohit J. Timal, Hein Putter, J. Wouter Jukema, Maurits S Buiten, Joris I. Rotmans, Véronique De Gucht, Liselotte C.R. Hensen, Ton J. Rabelink

Publikováno v: Quality of Life Research, 30(6), 1605-1617. Springer Science and Business Media LLC
Quality of Life Research
Quality of Life Research, 30(6), 1605-1617. SPRINGER

Rationale The impact of prophylactic implantable cardioverter-defibrillator (ICD) implantation on the psychological well-being of patients on dialysis is unknown. Objective We aimed to identify the effect of primary ICD implantation on quality of lif

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::422fc9c8d5e16e7b33640b00356d002b
https://doi.org/10.1007/s11136-020-02744-7

Cost-Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry

Autor: Johannes B. Van Rees, Mihály K. De Bie, Enno T. van der Velde, Martin J. Schalij, M. Elske van den Akker-van Marle, Joep Thijssen, Lieselot van Erven, C. Jan Willem Borleffs

Publikováno v: Pacing and Clinical Electrophysiology. 37:25-34

Background Although randomized trials have shown the beneficial effect on survival of an implantable cardioverter defibrillator (ICD) as primary prevention therapy in selected patients, data concerning the cost-effectiveness in routine clinical pract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a9e19faf881f0e9d94e4e4123e920713
https://doi.org/10.1111/pace.12238

Republished: How to reduce sudden cardiac death in patients with renal failure

Autor: J. Wouter Jukema, Maurits S Buiten, Ton J. Rabelink, Mihály K. de Bie

Publikováno v: Postgraduate Medical Journal, 88(1041), 418-424

Prevention of sudden cardiac death (SCD) is an important target for improving survival in various patient groups and many prevention options have been evaluated. In the past decade several trials have documented beneficial effects for implantable car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5bcb3019108660945f9fdc81e452705
https://doi.org/10.1136/postgradmedj-2011-300693rep

How to reduce sudden cardiac death in patients with renal failure

Autor: J. Wouter Jukema, Mihály K. de Bie, Maurits S Buiten, Ton J. Rabelink

Publikováno v: Heart, 98(4), 335-341

Prevention of sudden cardiac death (SCD) is an important target for improving survival in various patient groups and many prevention options have been evaluated. In the past decade several trials have documented beneficial effects for implantable car

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ef8fdbb76cdf76b05e04572d4da354
https://doi.org/10.1136/heartjnl-2011-300693